Table 3.
Variable | assisted | univariate | multivariable | |||||||
---|---|---|---|---|---|---|---|---|---|---|
% | SE | ORa | 95% CI | r-sq | AOR b | 95% CI | r-sq | |||
Demographics | ||||||||||
Gender | 0.00 | 0.01 | ||||||||
Female | 51.8 | 2.32 | 0.87 | (0.73, 1.04) | 0.88 | (0.73, 1.06) | ||||
Male | 55.3 | 2.17 | 1.00 | [Reference] | 1.00 | [Reference] | ||||
Age | 0.01 | 0.01 | ||||||||
18–24 yrs (emerging adulthood) | 54.4 | 8.56 | 1.29 | (0.85, 1.95) | 1.30 | (0.86, 1.97) | ||||
25–49 yrs (young adults) | 50.0 | 2.63 | 1.08 | (0.82, 1.42) | 1.11 | (0.83, 1.47) | ||||
50–64 yrs (mid-life stage adults) | 61.1 | 2.24 | 1.69 | (1.27, 2.26) | ** | 1.71 | (1.28, 2.28) | ** | ||
65+ yrs (older adults) | 48.1 | 2.84 | 1.00 | [Reference] | 1.00 | [Reference] | ||||
Race | 0.00 | 0.01 | ||||||||
White, Non-Hispanic | 53.4 | 1.84 | 1.00 | [Reference] | 1.00 | [Reference] | ||||
Black, Non-Hispanic | 57.9 | 4.66 | 1.20 | (0.92, 1.56) | 1.23 | (0.94, 1.60) | ||||
Other, Non-Hispanic | 60.2 | 8.13 | 1.32 | (0.89, 1.94) | 1.33 | (0.90, 1.97) | ||||
Hispanic | 50.4 | 4.51 | 0.89 | (0.70, 1.13) | 0.90 | (0.71, 1.15) | ||||
2+ Races, Non-Hispanic | 51.8 | 8.64 | 0.94 | (0.47, 1.85) | 0.91 | (0.46, 1.80) | ||||
Clinically relevant indices | ||||||||||
Time since problem resolution (in years) | 0.00 | 0.02 | ||||||||
0–5 years | 53.7 | 3.02 | 1.00 | [Reference] | 1.00 | [Reference] | ||||
5–15 years | 53.1 | 2.74 | 0.98 | (0.79, 1.21) | 0.90 | (0.71, 1.13) | ||||
15+ years | 54.7 | 2.44 | 1.04 | (0.83, 1.30) | 0.85 | (0.65, 1.11) | ||||
Number of substances used 10+ times c | 0.01 | 0.03 | ||||||||
1 substance | 46.1 | 3.05 | 1.00 | [Reference] | 1.00 | [Reference] | ||||
2 substances | 53.4 | 3.48 | 1.34 | (1.04, 1.72) | * | 1.32 | (1.02, 1.70) | * | ||
3+ substances | 58.5 | 2.21 | 1.65 | (1.33, 2.04) | ** | 1.63 | (1.31, 2.03) | ** | ||
Age of onset of first substance c | 0.01 | 0.02 | ||||||||
< 15 years of age | 58.8 | 2.32 | 1.47 | (1.23, 1.75) | ** | 1.46 | (1.21, 1.75) | ** | ||
> 15 years of age | 49.3 | 2.18 | 1.00 | [Reference] | 1.00 | [Reference] | ||||
Age of onset of problem substance c | 0.02 | 0.04 | ||||||||
< 15 years of age | 61.4 | 2.68 | 1.42 | (1.17, 1.73) | ** | 1.42 | (1.17, 1.74) | ** | ||
> 15 years of age | 52.8 | 2.14 | 1.00 | [Reference] | 1.00 | [Reference] | ||||
Primary substance c | 0.02 | 0.04 | ||||||||
Alcohol | 55.9 | 2.10 | 1.00 | [Reference] | 1.00 | [Reference] | ||||
Cannabis (e.g., marijuana, hashish) | 45.8 | 5.53 | 0.67 | (0.50, 0.90) | ** | 0.66 | (0.49, 0.89) | ** | ||
Cocaine (e.g., coke, crack, freebase) | 58.9 | 4.72 | 1.13 | (0.83, 1.54) | 1.03 | (0.75, 1.42) | ||||
Methamphetamine (crank, meth) | 59.7 | 6.32 | 1.17 | (0.82, 1.67) | 1.29 | (0.89, 1.85) | ||||
Opioids (e.g., heroin, methadone) | 71.5 | 6.75 | 1.98 | (1.27, 3.08) | ** | 2.17 | (1.38, 3.41) | ** | ||
Other | 53.8 | 9.44 | 0.92 | (0.53, 1.61) | 1.04 | (0.59, 1.83) | ||||
Lifetime mental health disorder diagnoses | ||||||||||
Substance use disorder (vs. not) | 90.2 | 1.89 | 10.64 | (7.33, 15.44) | ** | 0.12 | 10.81 | (7.42, 15.74) | ** | 0.13 |
Anxiety disorder (vs. not) | 68.4 | 2.84 | 2.19 | (1.75, 2.74) | ** | 0.02 | 2.40 | (1.90, 3.02) | ** | 0.04 |
Mood disorder (vs. not) | 67.1 | 3.22 | 1.97 | (1.56, 2.50) | ** | 0.02 | 2.12 | (1.66, 2.70) | ** | 0.03 |
Other disorder (vs. not) | 61.0 | 5.61 | 1.37 | (0.98, 1.92) | 0.00 | 1.46 | (1.04, 2.06) | * | 0.02 | |
Never been diagnosed (vs. not) | 38.9 | 2.25 | 0.30 | (0.25, 0.36) | ** | 0.08 | 0.27 | (0.23, 0.33) | ** | 0.10 |
History of involvement in a drug court b | 0.09 | 0.10 | ||||||||
Never been arrested | 39.8 | 2.17 | 1.00 | [Reference] | 1.00 | [Reference] | ||||
Arrested, no drug court | 64.3 | 2.37 | 2.72 | (2.25, 3.30) | ** | 2.79 | (2.29, 3.41) | ** | ||
Arrested, drug court | 83.1 | 4.09 | 7.47 | (4.81, 11.60) | ** | 8.06 | (5.15, 12.63) | ** |
Abbreviations:
OR, odds ratio;
AOR, adjusted odds ratio, adjusted for gender, age and race;
not shown are statistics for participants who did not answer this question, though they were included in analyses as a separate category as described in Table 1;
p < 0.05,
p < 0.01.